TheraPanacea
Maxime Guiblin has work experience in multiple companies. Maxime started their career as an Internship Trainee at Raydiall Automotive in 2017. In 2018, they joined Airbus as a Machine Learning Intern and later became a Software Engineer. Maxime has been with Airbus until 2022. Currently, Maxime Guiblin is working as a Software Engineer at TheraPanacea since October 2022.
Maxime Guiblin started their education in 2013 at Lycée Charlemagne in Paris, where they completed a Preparatory Class to Grandes Ecoles program focused on Mathematics and Physics. After completing this program in 2015, they went on to pursue a Master of Science (M.Sc.) degree in Integrated electronic systems at Grenoble INP - Phelma. Maxime successfully completed this degree in 2018, obtaining the diplôme d'ingénieur qualification.
This person is not in any offices
TheraPanacea
TheraPanacea is an innovative information technology company devoted to unlocking the power of AI-based solutions to drive innovation in healthcare. A spin-off of University Paris-Saclay, TheraPanacea works in close cooperation with the most prominent healthcare facilities to combine the power of its proprietary platforms with clinical domain-knowledge. Today, ART-Plan™, TheraPanacea dedicated suite for radio-oncology, is used by more than 60 cancer centres across Europe, Africa, Middle-East and the US and is helping to improve care for more than 60,000 patients every year. TheraPanacea also develops and operates the ART-Omics™ platform enabling pharmaceutical companies to accelerate clinical research by harnessing AI-based multi-modality biomarker discovery in clinical trials and their effective integration within the clinical workflow at scale in the form of certified medical devices.